Sign In
Buy HCAT
$2.09
+0.0100 (+0.481%)
At Close: Jul 31, 2026
Health Catalyst, Inc. (HCAT) Q1 2025 Earnings Call Transcript
07:33am, Thursday, 08'th May 2025
Health Catalyst, Inc. (NASDAQ:HCAT ) Q1 2025 Earnings Conference Call May 7, 2025 5:00 PM ET Company Participants Jack Knight - Vice President, Investor Relations Dan Burton - Chief Executive Officer
Health Catalyst (HCAT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
06:30pm, Wednesday, 07'th May 2025
The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street
Health Catalyst (HCAT) Q1 Earnings Meet Estimates
06:15pm, Wednesday, 07'th May 2025
Health Catalyst (HCAT) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.05 per share a year ago.
Health Catalyst Reports First Quarter 2025 Results
04:03pm, Wednesday, 07'th May 2025
SALT LAKE CITY, May 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizatio
Health Catalyst's Improvement Expertise Built on Microsoft Azure and Azure AI Foundry to Drive Reliable Insight and Sustained Outcomes for Care Providers SALT LAKE CITY , April 29, 2025 /PRNewswire/ -
Health Catalyst to Announce First Quarter 2025 Operating Results and Host Conference Call on Wednesday, May 7, 2025
08:00am, Thursday, 17'th Apr 2025
SALT LAKE CITY, April 17, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations
Beyond Tempus AI: 2 Health IT Stocks Poised for Growth in 2025
04:00pm, Thursday, 10'th Apr 2025
AI-driven healthcare companies like Butterfly Network and Health Catalyst have all the qualities to emerge as the next big players.
SALT LAKE CITY , April 10, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,
Health Catalyst: Share Price Continues To Dismiss Positive Earnings And Improved Outlook
03:53pm, Tuesday, 25'th Mar 2025
Despite a 50% drop in HCAT's stock price, the company shows significant growth, reporting $307M in revenue and $26M in adjusted EBITDA for 2024. Health Catalyst focuses on efficiency, exiting lower-ma
Is the Options Market Predicting a Spike in Health Catalyst (HCAT) Stock?
11:55am, Tuesday, 25'th Mar 2025
Investors need to pay close attention to Health Catalyst (HCAT) stock based on the movements in the options market lately.
Health Catalyst Announces ~$5 Million Stock Repurchase
08:30am, Tuesday, 11'th Mar 2025
SALT LAKE CITY , March 11, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,
Signature Healthcare to Enhance Analytics by Leveraging Health Catalyst Ignite™
04:05pm, Thursday, 27'th Feb 2025
SALT LAKE CITY , Feb. 27, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, to
Health Catalyst, Inc. (HCAT) Q4 2024 Earnings Call Transcript
11:23pm, Wednesday, 26'th Feb 2025
Health Catalyst, Inc. (NASDAQ:HCAT ) Q4 2024 Earnings Call Transcript February 26, 2025 5:00 PM ET Company Participants Jack Knight - Vice President, Investor Relations Dan Burton - Chief Executive Of
Compared to Estimates, Health Catalyst (HCAT) Q4 Earnings: A Look at Key Metrics
08:00pm, Wednesday, 26'th Feb 2025
Although the revenue and EPS for Health Catalyst (HCAT) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with W
Health Catalyst (HCAT) Misses Q4 Earnings and Revenue Estimates
07:10pm, Wednesday, 26'th Feb 2025
Health Catalyst (HCAT) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.02 per share a year ago.
